Anal Cancer
Curative Option Identified for Squamous Cell Carcinoma of the Anal Canal With Distant Metastasis
November 30, 2018A retrospective review identified a subset of patients with squamous cell carcinoma of the anal canal with distant metastases who respond to extended-field chemoradiation.
Higher Socioeconomic Status Leads to Improved Survival Outcomes in Anal Cancer
March 13, 2018A multivariable analysis revealed how median household income influences cancer-specific and overall survival among patients with squamous cell carcinoma of the anus.
HPV and Cancer (Fact Sheet)
November 02, 2017This fact sheet examines possible links between human papillomaviruses (HPVs) and cancer.
HPV Vaccination Discussions Need to Focus on Education, Awareness
March 13, 2017The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.
Nivolumab Shows Promise Against Aggressive Anal Cancer
April 29, 2016Clinical trial results are promising for the use of nivolumab to treat squamous cell carcinoma of the anal canal, according to data presented at the 2016 American Association for Cancer Research Annual Meeting.
High-risk HPV Infection Increases Risk for Anal Cancer
March 07, 2016Anal cancer is associated with human papillomavirus (HPV) infection, and some women are at increased likelihood of have both diseases.
HPV16 seropositivity common before anal cancer diagnosis
February 12, 2015Human papillomavirus type 16 seropositivity is fairly common before an anal cancer diagnosis, according to a study, and seropositivity tends to increase in blood samples drawn closer to time of cancer diagnosis.
HPV16 seropositivity relatively common prior to diagnosis of anal cancer
February 11, 2015Human papillomavirus (HPV) type 16 (HPV16) seropositivity is relatively common in people prior to receiving a diagnosis of anal cancer.
Despite cART, anal cancer risk still high for HIV-infected
December 12, 2012High incidence compared to general population, especially for men who have sex with men.
No benefit of induction chemo, high-dose boost in anal cancer
April 27, 2012Colostomy-free survival not improved in patients with locally advanced anal canal carcinoma.
Cancer risk doubles for organ-transplant recipients
November 21, 2011Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have twice as great a risk for diverse infection-related and unrelated cancers.
HPV vaccine protects men from anal cancer
November 14, 2011A quadrivalent human papillomavirus (HPV) vaccine to prevent anal cancer was shown to be safe and effective in a trial of healthy men who have sex with men.
IMRT a less toxic form of radiation in anal cancer
February 01, 2011A novel chemoradiation regimen for the treatment of anal cancer is proven to have fewer significant side effects than conventional therapy.
HPV vaccine gets nod for prevention of anal cancer
January 03, 2011The FDA has approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions caused by HPV for males and females aged 9 through 26 years.
Sign Up for Free e-newsletters
ONA Articles
- Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?
- Recommended Therapies for Polycythemia Vera Underused
- PFS, OS Improved With Sequential Rituximab/Bendamustine, Rituximab/Cytarabine in Untreated Mantle Cell Lymphoma
- ADT May Up Risk for Heart Failure in Prostate Cancer Patients
- Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value
- Smartphone App Improves Management of Cancer-Related Pain, Anxiety
- Counseling Patients on Oral Chemotherapy
- Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?
- Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit
- Prophylaxis Improves Postchemotherapy Nausea/Vomiting Frequency, Hospitalizations
- Steering Patients Toward Reliable Internet Resources
- Postmastectomy Breast Reconstruction Safe in Older Women With Breast Cancer
- CIPN in Breast Cancer: Do Subjective and Objective Measures Correlate?
- Risk of Breast Cancer Higher for African American Female Veterans
- Patients, Physicians Do Not Recognize Fatigue the Same
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |